Interview: Juan Ángeles Uribe – CEO, Laboratorios Carnot – México
Innovation is a product’s added value, ensuring that the patient is ready to buy. The former director of R&D and today CEO of Carnot explains how the company is undergoing…
Carnot Laboratories is a 100% Mexican company focused on high technology systems in the manufacturing of their products. The company considers the launch of innovative products and continuous product renewal the cornerstone of its growth in order to meet the current requirements of the population. Carnot’s manufacturing facilities have been certified by COFEPRIS, INVIMA, ANVISA and ANMAT and is now present all over Central and South America, with affiliates in Argentina, Peru, Colombia and Uruguay.
Carnot ® Laboratories adds value through its business philosophy, offering manufacturing in areas such as hormonal injectables, oral solids, oral liquids, semisolids, conditioning and inhaled biological products that meet national and international quality standards. Carnot products are based on years of experience and technological innovation.
Contact Details:
Carnot Laboratorios
Heriberto Frías 1035
Colonia del Valle
C.P. 03100 México, D.F.
MEXICO
Telephone: (+52) 555488-7000
Innovation is a product’s added value, ensuring that the patient is ready to buy. The former director of R&D and today CEO of Carnot explains how the company is undergoing…
Dr. Teresa Corona Vázquez, the general director of one of the leading neuroscience institutions in Latin America, details their most important research partnerships and achievements, notably with regards to neurodegenerative…
Juan Fransisco Millán Sobaranes of Cetifarma, the council created by the pharmaceutical industry in Mexico for ethics and transparency, discussed the agency’s major milestones and its main priorities for ensuring…
Building on the continuous improvements of the Federal Commission for the Protection Against Sanitary Risk (Cofepris) over the last few years, its recently-appointed Federal Commissioner Julio Sánchez y Tépoz reveals…
Socorro España Lomelí, executive director of Mexico’s National Association of Drug Manufacturers (ANAFAM), details her strategic priorities with regards to the promotion of the industry’s export strategy, the implementation of…
Rafael Gual, general director of CANIFARMA, the chamber that brings together multinational and local drug manufacturers, details how the organization is currently intensifying its efforts to ensure the pharmaceutical industry…
Although the country is moving in the right direction with regards to universal coverage, a number of barriers to effective implementation remain. 57.3 million previously uninsured Mexicans are now enrolled…
PharmaBoardroom spoke to Fabrice Chouraqui, President of Novartis Latin America and Canada at the Financial Times LatAm Healthcare & Life Sciences Summit in September 2015. He emphasizes the criticality of…
Two companies from two different countries chose Mexico as their entry market to Latin America. The heads of these companies spoke to PharmaBoardroom about their market entry strategies. Edmée Stenken,…
The industry of medical devices is soaring in Mexico. The general manager of ConvaTec discusses strategic priorities, new approaches and how reduced time to market is feeding the double-digit growth…
IMS Health recently released its World Review 2015. The new general manager of North Latin America shares the company’s assessment on the performance of the Mexican pharmaceutical market for 2014,…
The industry of medical devices is still not very well understood. Pablo Dávila shared with us his overview on the Mexican market, how the Mexican Association of Innovative Medical Device…
The technical & RA director and the managing director of Qually Corporacion explain how authorized third partied act as an extension of the regulative body, Cofepris, helping to assure that…
See our Cookie Privacy Policy Here
